Investment thesis TearLab Corp (TEAR) has so far managed to drive moderate increases in revenue over the past year, but only by spending a disproportionate amount on marketing. The result has been ballooning losses in every quarter. The company has never earned a profit. Following dozens of recent calls to the offices of eye doctors,…
On Wednesday August 7th, Biolase Inc (BIOL) announced Q2 results. The company missed analyst estimates by 2 cents and updated investors with guidance at the lower end of previously given ranges. Missing earnings is never a good thing. But as earnings misses go, this one was certainly not catastrophic. Despite the moderate nature of the miss, shares…
I last wrote about Organovo Holdings (ONVO) on July 24th. Since my last article, there have been several new developments which further reinforce the short thesis on the stock. The stock has continued to fall as expected. First, the S3 registration statement for up to $100 million of new shares and/or warrants has now become…
Organovo (ONVO) is about as hot as any concept stock could ever be right now. It sits right at the crossroads of 3D printing and regenerative biotechnology. In addition, Organovo just uplisted from the OTCBB to the NYSE, further fueling the strong enthusiasm. Following the uplist, Organovo soared from $3.90 to $8.50, a gain of…
Not long ago, ZM Funds was in a serious pickle. It was the largest holder of $120 million in second lien debt from a deeply distressed helicopter operator called Evergreen Helicopter. Evergreen has received a going concern letter from their auditor. It was in default on its debt. It was not even paying its accounts payable to such an extent that suppliers began…
On Wednesday, ChinaBak Battery (CBAK) jumped by as much as 65% to $1.63 on tremendous volume following widely circulated (but entirely false) rumors that the company will be supplying lithium ion batteries to Kandi Technologies (KNDI). On the previous day ChinaBak had been trading at around 90 cents, with a market cap of just $10…
Shares of TearLab (TEAR) have nearly doubled in 2013, buoyed by a stream of analyst upgrades from small, retail oriented brokerages. However, it now looks as if a near term equity offering will likely take the shares lower. Investment thesis Despite the recent bullish analyst reports, financial performance at TearLab has been consistently very poor….
Disclosure: I am short OPK. (More…) When I first raised the alarm about Ziopharm Oncology (ZIOP), I received death threats and threats of lawsuits from many retail investors. Some of these can still be found posted online. Many retail investors were so enthralled with this “guaranteed winner” that any suggestion to sell by anyone at any price was shouted down…
Shares of Opko Health (OPK) have risen 65% in the past three months as a string of domestic and international acquisitions, along with a greater collaboration with Bristol Meyers (BMY), has opened up numerous new pathways for the company. Opko’s prospects as a company continue to be bright, however at the current price of…
Shares of Unipixel have dropped 30% from their high in the last 2 weeks right as MDB capital pulled all of its research from the MDB website. Additional case studies of MDB deals had also been removed from MDB presentations. I have located archived copies which disclose the use of unregistered analysts who write the reports from Nicaragua as well as MDB’s right to go short the stock of companies it has promoted. MDB had taken large equity stakes (including free warrants) prior to publishing its bullish research.
A factory explosion left Neptune Technologies (NEPT) with no factory, no revenues, no product and only 10 employees. Despite this, an aggressive promotion to retail investors by 3rd parties has suggested the share price should double to all time highs. In reality, the share price is more likely to fall by 50-70%.
Normally I try to shy away from very low priced stocks, however in the case of China BAK Battery (CBAK), it is a company which I have been quite familiar with for years while living in China. I am very well informed about the company’s complete insolvency as well as the unusual rise in its…
Cleantech Solutions (CLNT) is a tiny $12.0 million market cap company which describes its business as the manufacture of forged and fabricated products for end use primarily by manufacturers of windmills in China. The share price has nearly doubled in just the past week. The share price history of Cleantech is very confusing to some…
